Rallybio Corporation (RLYB) Earning

$0.40

$0.05 (-11.29%)
Last update: 04:00 PM EST
Day's range
$0.39
Day's range
$0.45

Rallybio Corporation Analyst EPS Estimates

Quarter Number of Estimates Low Estimate High Estimate Average Estimate
Q1 2025 1 -$0.26 -$0.26 -$0.26
Q2 2025 2 -$0.25 -$0.22 -$0.24
Q3 2025 1 -$0.20 -$0.20 -$0.20
Q4 2025 1 -$0.19 -$0.19 -$0.19
Q1 2026 1 -$0.24 -$0.24 -$0.24
Q2 2026 1 -$0.26 -$0.26 -$0.26
Q3 2026 1 -$0.29 -$0.29 -$0.29
Q4 2026 1 -$0.31 -$0.31 -$0.31

Rallybio Corporation Earnings Date And Information

Rallybio Corporation last posted its earnings results on Thursday, May 8th, 2025. The company reported $-0.21 earnings per share for the quarter, missing analysts' consensus estimates of $-0.21 by $0. The company had revenue of 212.00 K for the quarter and had revenue of 636.00 K for the year. Rallybio Corporation has generated $-1 earnings per share over the last year ($-1.33 diluted earnings per share) and currently has a price-to-earnings ratio of -0.37. Rallybio Corporation has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 7th, 2025 based on prior year's report dates.

Rallybio Corporation Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
05/08/2025 Q1 2025 -$0.21 -$0.21 0 $13.33 K $212.00 K
03/13/2025 Q4 2024 -$0.27 -$0.25 0.02 $149.50 K $38.00 K
11/07/2024 Q3 2024 -$0.36 -$0.26 0.1 $75.00 K $299.00 K
08/08/2024 Q2 2024 -$0.42 -$0.37 0.05 $166.67 K $299.00 K
05/09/2024 Q1 2024 -$0.50 -$0.47 0.03 N/A $0
03/12/2024 Q4 2023 -$0.44 -$0.50 -0.06 N/A $228.00 K
11/09/2023 Q3 2023 -$0.51 -$0.45 0.06 N/A $0
08/08/2023 Q2 2023 -$0.48 -$0.46 0.02 N/A $0
05/09/2023 Q1 2023 -$0.50 -$0.39 0.11 N/A $0
03/06/2023 Q4 2022 -$0.63 -$0.46 0.17 N/A $0
11/07/2022 Q3 2022 -$0.54 -$0.58 -0.04 N/A $0
08/08/2022 Q2 2022 -$0.61 -$0.57 0.04 N/A $0
05/10/2022 Q1 2022 -$0.48 -$0.47 0.01 N/A $0
03/15/2022 Q4 2021 -$0.39 -$0.42 -0.03 N/A $0
11/10/2021 Q3 2021 -$0.89 -$0.37 0.52 N/A $0
09/09/2021 Q2 2021 -$2.80 -$0.36 2.44 N/A $0
03/30/2021 Q1 2021 N/A -$0.60 N/A N/A $0
12/30/2020 Q4 2020 N/A -$0.47 N/A N/A $0
09/29/2020 Q3 2020 N/A -$0.32 N/A N/A $0
06/29/2020 Q2 2020 N/A -$0.22 N/A N/A $0

Rallybio Corporation Earnings: FAQ's

Rallybio Corporation has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 7th, 2025 based offlast year's report dates.

The conference call for Rallybio Corporation's latest earnings report can be listened to online.

The conference call transcript for Rallybio Corporation's latest earnings report can be read online.

Rallybio Corporation (:RLYB) has a recorded annual revenue of $636.00 K.

Rallybio Corporation (:RLYB) has a recorded net income of $-57,775,000.Rallybio Corporation has generated $-1.33 earnings per share over the last four quarters.

Rallybio Corporation (:RLYB) has a price-to-earnings ratio of -0.37 and price/earnings-to-growth ratio is -0.02.

Portfolio Sync
Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED